FDA– tag –
-
Intellia Therapeutics Advances CRISPR Gene Editing: Lonvo-z Achieves Phase 3 Success for HAE, Targeting Mid-2027 U.S. Launch; Nex-z Phase 3 Enrollment Resumes for ATTR
Intellia Therapeutics, Inc. (Press Release) USA Overview Intellia Therapeutics reported positive Phase 3 results for lonvo-z in hereditary angioedema (HAE), with a Biologics License Application (BLA) submission to the FDA planned for H2 ... -
FDA Advances AI Medical Device Regulation Clarity Amidst “AI Premium” Driving Investment, Challenges Remain for Generative AI
Facebook (STAT News) USA Overview The MedTech industry experienced a strategic reset, with AI-enabled companies commanding a 19% premium on average deal size in 2025, and US startups raising $14.2 billion. While the FDA is updating guida... -
Challenges in Rapid AI Tool Development and Deployment in Clinics: Data Privacy, Algorithmic Bias, and Regulatory Delays
Facebook (STAT News) USA Overview The rapid development and deployment of clinical AI tools raise significant challenges and ethical concerns, including data privacy risks, algorithmic bias, and the 'black box' nature of many AI models. ... -
Cultivated Meat Commercialization Accelerates in Singapore and U.S.: Aleph Farms Approved for Beef Steak, Market Projected to Reach $5.6 Billion by 2036
BioInformant Singapore Overview Cultivated meat commercialization is gaining traction, with Aleph Farms securing Singapore's SFA approval for its Thin-Cut Steak, making it the world's first cultivated beef product to market. This follows... -
FDA Finalizes Flexible CMC Framework, Ending ‘Rule of Three’ for Cell and Gene Therapy Approvals
BioProcess International USA Overview The FDA has issued a finalized "Level 2" guidance document for Chemistry, Manufacturing, and Controls (CMC) flexibilities in cellular and gene therapy (CGT) products, effectively concluding the "Rule... -
Biopharma’s Evolving Blueprint: AGC Biologics Expands Global Capacity, Enzene Drives Continuous Manufacturing Adoption
Pharma Manufacturing USA Overview This news digest highlights several pivotal developments in the biopharmaceutical manufacturing sector, showcasing an industry-wide acceleration towards enhanced capacity and technological innovation. Ke... -
AGC Biologics Commits Half of New Yokohama Biomanufacturing Plant to Major Long-Term Deal
Megaproject Japan Overview AGC Biologics has secured a significant multi-million dollar, long-term commercial manufacturing contract with an undisclosed pharmaceutical firm for its new Yokohama facility, set to open in 2027. This landmar... -
Health Electronics Summit 2026 Hosted by Wibu-Systems: Discussing Cybersecurity and Regulatory Compliance for AI-Powered Medical Devices and Wearables
Wibu-Systems Germany Overview The Health Electronics Summit 2026, hosted by Wibu-Systems, focuses on secure product development, protected communication, trustworthy AI, and robust update processes in digital health. The summit will addr... -
UnitedHealthcare Updates CGM and Insulin Delivery Coverage Policy: Non-Invasive CGMs Excluded Due to Lack of Evidence
UHC Provider Portal (UnitedHealthcare) USA Overview UnitedHealthcare (UHC) has updated its medical policy regarding coverage for continuous glucose monitoring (CGM) and insulin delivery systems for diabetes management. The updated policy... -
Cutting-Edge Sensing Technologies Combat Food Adulteration: Electrochemical DNA Biosensor Identifies Porcine DNA in Processed Meats
Analytical Methods International Overview Modern sensing technologies, particularly electrochemical and optical biosensors, are making significant strides in combating food adulteration. A recent review highlighted a label-free electroch...
